PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study
Titel:
PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study
Auteur:
Ferrarotto, Renata Swiecicki, Paul L. Zandberg, Dan P. Baiocchi, Robert A. Wesolowski, Robert Rodriguez, Cristina P. McKean, Meredith Kang, Hyunseok Monga, Varun Nath, Rajneesh Palmisiano, Neil Babbar, Naveen Sun, William Hanna, Glenn J.